Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPERIAL Study
ChiCTR-ONC-13003733Phase 4Recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of iodixanol in coronary arteriosclerosis, sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Overall incidence of MACCE from PCI to 72 hours post-PCI. Started Oct 2013; status: recruiting.
02
Drugs
iodixanol
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-ONC-13003733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-13003733.